All News

Guest Lecture at the Risk Center Seminar Series by Dr. Filipe Barata on “Days of Future Health: Digital Biomarkers and Beyond”

Dr. Filipe Barata will give a guest lecture in the upcoming Seminar Series of the ETH Risk Center on the topis of “Days of Future Health: Digital Biomarkers and Beyond”. The talk will take place online on Tuesday, 26 October 2021, from 12:15 pm to 1:30 pm and includes an open discussion.

Participation in the talk is free and no registration is required.

Abstract

The widespread use of mobile technologies (e.g. wearable sensors, mobile applications, social media, and location-tracking technologies) has the potential to meet the health monitoring needs of the world’s aging population and the ever-growing number of chronic patients. However, this premise is based on the application of ML algorithms that allow us to use this data in many different ways. This presentation will discuss the application of ML in mobile health and the key challenges and risks associated with it.

About Dr. Filipe Barata

Filipe Barata is a postdoctoral fellow and serves as the Core Director for AI & Digital Biomarker, Acoustic and Inflammatory Biomarkers at the Center for Digital Health Interventions at ETH Zurich. He investigates the potential that mobile technologies such as wearable sensors, mobile applications, social media, and location-tracking technologies can offer for the monitoring and self-management of people with chronic diseases. Filipe Barata holds a diploma (M.Sc.) in electrical engineering and information technology at ETH Zurich. Before joining the Center for Health Interventions, where he obtained his PhD, he worked in the research department of Bruker Biospin, where he developed algorithms for the autonomous interpretation of NMR spectra. In his professional career he gained experience in several research laboratories, including the Department of Biomedical Data Science at the Geisel School of Medicine at Dartmouth College and the R&D department of LMS International (Siemens).

Share this post